Respiratory disease Archives

Latest Posts

News and Trends 24 Sep 2015

Crowdsourcing for Innovation: BioMed X has just the right Recipe

Ever heard of BioMed X? If you are curious about innovation crowdsourcing, you should definitely check them out. BioMed X is one of the first companies to use crowdsourcing to discover new innovation in the life sciences, through which a biotech team has been assembled and financed to develop a new treatment for COPD. Chronic obstructive pulmonary […]

September 24, 2015 - 2 minutesmins - By Joachim Eeckhout

News and Trends 14 Sep 2015

64 million infected: A brief overview of ReViral and its RSV vaccine competition

Respiratory Syncytial Virus (RSV) affects millions annually, therefore attracting many large biotechs to research a vaccine. ReViral (London, UK) has secured €18.5M series A investment into its pre-clinical pipeline. VC investors Edmond de Rothschild, OrbiMed and Brace Pharma Capital back this award winning antiviral program, despite an array of competitors. ReViral have got the go […]

September 14, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 7 Aug 2015

Bill & Melinda Gates’ Faith in CureVac is Leading to a New Program

CureVac, a pioneer in the field of mRNA-based technology, today announced that the company has initiated its third target product development program in collaboration with the Bill & Melinda Gates Foundation. The program will leverage CureVac’s RNActive technology platform in the development of a prophylactic vaccine to protect against respiratory syncytial virus (RSV), adding to […]

August 7, 2015 - 2 minutesmins - By Joachim Eeckhout

News and Trends 29 Jul 2015

Effective Antibody from a Patient recovering from Middle East Respiratory Syndrome

Two months after the outbreak of the coronavirus in South Korea, researchers are presenting first results of an effective treatment for the Middle East Respiratory Syndrome (MERS). The Swiss biotech Humabs BioMed has been able to isolate an effective antibody from a cured patient that should now be further developed under a non-profit base. In 2012, […]

July 29, 2015 - 3 minutesmins - By Philip Hemme

News and Trends 11 Jun 2015

Pieris Pharma: is it worth going to NASDAQ for only €31 Million?

Pieris Pharmaceutical is planning to raise €31M in an surprisingly low US IPO. The company seeks to advance its early-stage pipeline with a special focus on its anemia treatment, Pieris’s most advanced candidate which recently completed the enrollment of its Phase I. Pieris’ pipeline might be premature, but it is ambitious. The company’s focus includes […]

June 11, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 26 Feb 2015

Unstoppable Ferring after the Acquisition of a novel Oral Drug Delivery Technology

Ferring Pharmaceuticals signed an agreement with South Korean CTCBIO to acquire rights to a novel oral drug delivery technology. The Swiss company is growing more and more rapidly with plenty of updates since the begining of the year. Ferring’s success in developing oral formulations for peptide drugs including the world’s first orally active peptide, desmopressin […]

February 26, 2015 - 2 minutesmins - By Lourdes Riquelme

Resources

Categories

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

Approaches

Therapeutic areas

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us